VERY LATE STENT THROMBOSIS AFTER JOHNSON & JOHNSON/JANSSEN VACCINATION
Sign Up to like & getrecommendations! Published in 2022 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(22)04316-9
Abstract: Background: Stent thrombosis (ST) is a dreaded complication of percutaneous coronary intervention (PCI), however incidence has been declining with improvement in stent design and pharmacological treatments. While ST can occur at any time after placement… read more here.
Keywords: johnson johnson; stent thrombosis; johnson; johnson janssen ... See more keywords
E088 Safety of guselkumab in patients with psoriatic disease: an integrated analysis of 11 Phase 2 and 3 clinical studies in psoriasis and psoriatic arthritis
Sign Up to like & getrecommendations! Published in 2023 at "Rheumatology"
DOI: 10.1093/rheumatology/kead104.337
Abstract: Guselkumab is a monoclonal antibody approved to treat moderate-to-severe plaque psoriasis and active psoriatic arthritis (PsA). In this analysis, safety data from 11 Phase 2/3 studies of guselkumab were pooled to evaluate guselkumab safety in… read more here.
Keywords: scientific affairs; johnson johnson; johnson; janssen scientific ... See more keywords
National League for Nursing/Johnson & Johnson Project: Transitioning Senior Nursing Students in Historically Black Colleges and Universities Into Clinical Practice
Sign Up to like & getrecommendations! Published in 2022 at "Nursing Education Perspectives"
DOI: 10.1097/01.nep.0000000000000946
Abstract: TheNational League for Nursing (NLN) and Johnson & Johnson (J&J) established a partnership in 2021 to address current and looming health care challenges. The growing shortage of nurses exacerbates the steadily increasing complexity of the… read more here.
Keywords: johnson johnson; historically black; nursing; johnson ... See more keywords
Johnson and Johnson pays $120m to settle hip implant claims from 46 US states
Sign Up to like & getrecommendations! Published in 2019 at "British Medical Journal"
DOI: 10.1136/bmj.l402
Abstract: Johnson and Johnson, and its subsidiary DePuy Orthopaedics, have agreed to pay $120m (£92m; €106m) to settle claims from a coalition of attorneys-general from 46 US states that they endangered consumers by falsely advertising and… read more here.
Keywords: johnson johnson; hip; johnson pays; 120m settle ... See more keywords